Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 20 studies | 40% ± 15% | |
intestine | 10 studies | 38% ± 16% | |
kidney | 8 studies | 26% ± 14% | |
brain | 8 studies | 28% ± 8% | |
peripheral blood | 5 studies | 27% ± 9% | |
uterus | 5 studies | 58% ± 21% | |
prostate | 5 studies | 50% ± 22% | |
liver | 5 studies | 31% ± 8% | |
pancreas | 4 studies | 35% ± 14% | |
placenta | 4 studies | 51% ± 25% | |
adipose | 4 studies | 34% ± 7% | |
esophagus | 4 studies | 48% ± 27% | |
skin | 4 studies | 53% ± 27% | |
breast | 4 studies | 68% ± 15% | |
eye | 3 studies | 48% ± 25% | |
heart | 3 studies | 24% ± 3% | |
adrenal gland | 3 studies | 19% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 22860.63 | 966 / 966 | 100% | 180.53 | 526 / 527 |
skin | 100% | 52630.41 | 1809 / 1809 | 100% | 440.22 | 471 / 472 |
uterus | 100% | 33255.00 | 170 / 170 | 100% | 288.53 | 458 / 459 |
esophagus | 100% | 26956.30 | 1445 / 1445 | 99% | 236.21 | 182 / 183 |
thymus | 100% | 21505.96 | 651 / 653 | 100% | 228.67 | 603 / 605 |
breast | 100% | 32603.47 | 459 / 459 | 99% | 202.10 | 1104 / 1118 |
lung | 99% | 25294.20 | 575 / 578 | 99% | 188.57 | 1143 / 1155 |
bladder | 100% | 23035.86 | 21 / 21 | 98% | 224.36 | 496 / 504 |
prostate | 100% | 18178.02 | 245 / 245 | 98% | 100.56 | 493 / 502 |
ovary | 100% | 24000.27 | 180 / 180 | 98% | 120.01 | 422 / 430 |
adrenal gland | 100% | 20716.67 | 258 / 258 | 97% | 137.17 | 224 / 230 |
stomach | 97% | 18323.02 | 348 / 359 | 99% | 158.59 | 284 / 286 |
kidney | 99% | 13198.02 | 88 / 89 | 93% | 120.79 | 841 / 901 |
pancreas | 67% | 5273.16 | 221 / 328 | 99% | 257.76 | 177 / 178 |
liver | 65% | 5031.21 | 146 / 226 | 100% | 153.00 | 404 / 406 |
adipose | 100% | 36374.83 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 424.58 | 80 / 80 |
tonsil | 0% | 0 | 0 / 0 | 100% | 275.50 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 171.99 | 1 / 1 |
blood vessel | 100% | 37156.02 | 1333 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 13673.74 | 791 / 803 | 0% | 0 | 0 / 0 |
spleen | 98% | 11052.62 | 236 / 241 | 0% | 0 | 0 / 0 |
heart | 97% | 16984.99 | 832 / 861 | 0% | 0 | 0 / 0 |
brain | 15% | 1079.88 | 385 / 2642 | 60% | 42.50 | 426 / 705 |
lymph node | 0% | 0 | 0 / 0 | 72% | 47.75 | 21 / 29 |
peripheral blood | 20% | 3322.25 | 187 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0055015 | Biological process | ventricular cardiac muscle cell development |
GO_1903243 | Biological process | negative regulation of cardiac muscle hypertrophy in response to stress |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0051664 | Biological process | nuclear pore localization |
GO_0006998 | Biological process | nuclear envelope organization |
GO_0030951 | Biological process | establishment or maintenance of microtubule cytoskeleton polarity |
GO_0090435 | Biological process | protein localization to nuclear envelope |
GO_0072201 | Biological process | negative regulation of mesenchymal cell proliferation |
GO_1990683 | Biological process | DNA double-strand break attachment to nuclear envelope |
GO_0090201 | Biological process | negative regulation of release of cytochrome c from mitochondria |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0031507 | Biological process | heterochromatin formation |
GO_0030334 | Biological process | regulation of cell migration |
GO_0034504 | Biological process | protein localization to nucleus |
GO_0006606 | Biological process | protein import into nucleus |
GO_0007097 | Biological process | nuclear migration |
GO_2001237 | Biological process | negative regulation of extrinsic apoptotic signaling pathway |
GO_0090398 | Biological process | cellular senescence |
GO_1900180 | Biological process | regulation of protein localization to nucleus |
GO_0031647 | Biological process | regulation of protein stability |
GO_0071456 | Biological process | cellular response to hypoxia |
GO_0005638 | Cellular component | lamin filament |
GO_0016607 | Cellular component | nuclear speck |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005635 | Cellular component | nuclear envelope |
GO_0016363 | Cellular component | nuclear matrix |
GO_0005652 | Cellular component | nuclear lamina |
GO_0005829 | Cellular component | cytosol |
GO_0031965 | Cellular component | nuclear membrane |
GO_0035861 | Cellular component | site of double-strand break |
GO_0005634 | Cellular component | nucleus |
GO_0005200 | Molecular function | structural constituent of cytoskeleton |
GO_0160123 | Molecular function | structural constituent of nuclear lamina |
GO_0005515 | Molecular function | protein binding |
Gene name | LMNA |
Protein name | Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] Lamin A/C Prelamin-A/C (Rhabdomyosarcoma antigen MU-RMS-40.12) Epididymis secretory sperm binding protein (Lamin A/C transcript variant 1) |
Synonyms | LMN1 |
Description | FUNCTION: [Lamin-A/C]: Lamins are intermediate filament proteins that assemble into a filamentous meshwork, and which constitute the major components of the nuclear lamina, a fibrous layer on the nucleoplasmic side of the inner nuclear membrane . Lamins provide a framework for the nuclear envelope, bridging the nuclear envelope and chromatin, thereby playing an important role in nuclear assembly, chromatin organization, nuclear membrane and telomere dynamics . Lamin A and C also regulate matrix stiffness by conferring nuclear mechanical properties . The structural integrity of the lamina is strictly controlled by the cell cycle, as seen by the disintegration and formation of the nuclear envelope in prophase and telophase, respectively . Lamin A and C are present in equal amounts in the lamina of mammals . Also invoved in DNA repair: recruited by DNA repair proteins XRCC4 and IFFO1 to the DNA double-strand breaks (DSBs) to prevent chromosome translocation by immobilizing broken DNA ends . Required for normal development of peripheral nervous system and skeletal muscle and for muscle satellite cell proliferation . Required for osteoblastogenesis and bone formation . Also prevents fat infiltration of muscle and bone marrow, helping to maintain the volume and strength of skeletal muscle and bone . Required for cardiac homeostasis . .; FUNCTION: [Prelamin-A/C]: Prelamin-A/C can accelerate smooth muscle cell senescence . It acts to disrupt mitosis and induce DNA damage in vascular smooth muscle cells (VSMCs), leading to mitotic failure, genomic instability, and premature senescence . . |
Accessions | ENST00000674720.1 ENST00000473598.6 [P02545-5] ENST00000675939.1 [P02545-1] A0A6Q8PFM1 Q5TCI8 W8QEH3 D6RB20 A0A6Q8PF59 ENST00000676208.1 ENST00000677389.1 [P02545-2] ENST00000515459.5 ENST00000368297.5 ENST00000361308 A0A6Q8PHQ9 ENST00000675667.1 ENST00000504687.7 ENST00000448611.6 [P02545-4] ENST00000368299.7 [P02545-6] ENST00000361308.9 [P02545-1] A0A6Q8PGH0 P02545 ENST00000684195.1 ENST00000674518.1 ENST00000676434.1 ENST00000675874.1 ENST00000675455.1 A0A804HL68 ENST00000368301.6 [P02545-2] ENST00000676385.2 [P02545-3] ENST00000675881.1 Q5I6Y5 A0A6Q8PFF5 H0YAB0 ENST00000674600.1 ENST00000368300.9 [P02545-1] ENST00000683032.1 [P02545-1] ENST00000682650.1 [P02545-3] A0A6Q8PF80 A0A6Q8PFJ0 Q3BDU5 |